ESC Professional Premium Access

Diabetes may modify the efficacy of primary prevention implantable cardioverter-defibrillators in non-ischemic systolic heart failure: an extended follow-up of the DANISH trial

Topic: Implantable Cardioverter-Defibrillator (ICD)

Congress Session

About the speaker

Doctor Seiko N Doi

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

5 more presentations in this session

Biomarker profiles and pathophysiological pathways in patients with chronic heart failure and metabolic syndrome

Speaker: Miss C. Van Der Hoef (Groningen, NL)

Thumbnail

Timing of initiation of sodium-glucose co-transporter 2 inhibitor in patients with diabetes and chronic cardiac failure

Speaker: Doctor W. Sun (Shatin, HK)

Thumbnail

Prediabetes relates to impaired mitochondrial function in human ventricular myocardium

Speaker: Mr E. Zweck (Dusseldorf, DE)

Thumbnail

Outcomes in hospitalised diabetic ketoacidosis patients with underlying heart failure: a national inpatient sample analysis

Speaker: Doctor S. Yalamanchili (Greenville, US)

Thumbnail

Risk of heart failure following short-term non-steroidal anti-inflammatory drug use in patients with type 2 diabetes mellitus

Speaker: Mr J. Strange (Hellerup, DK)

Thumbnail

Access the full session

Chronic heart failure and diabetes

Speakers: Doctor S. N Doi, Miss C. Van Der Hoef, Doctor W. Sun, Mr E. Zweck, Doctor S. Yalamanchili...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk